Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMID 7256087)

Published in Rev Infect Dis on September 25, 1981

Authors

C V Broome, R R Facklam

Articles citing this

Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: characterization of "Atypical" pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes. Infect Immun (2000) 4.26

Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob Agents Chemother (1992) 3.39

Characterization of nontypable Streptococcus pneumoniae-like organisms isolated from outbreaks of conjunctivitis. J Clin Microbiol (1982) 1.54

Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol (1989) 1.48

Comparison of five genotypic techniques for identification of optochin-resistant pneumococcus-like isolates. J Clin Microbiol (2003) 1.30

Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect (1996) 1.02

Analysis of the genetic structure of nontypeable pneumococcal strains isolated from conjunctiva. J Clin Microbiol (2005) 1.02

Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. Aging Dis (2011) 0.93

Serotypes of Streptococcus pneumoniae blood culture isolates from adults in Franklin County, Ohio. J Clin Microbiol (1994) 0.86

Epidemiology of pneumococcal disease in a national cohort of older adults. Infect Dis Ther (2014) 0.81

Distribution of capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae isolated from aborigines in central Australia. J Clin Microbiol (1996) 0.80

Articles by these authors

Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl Microbiol (1972) 13.09

Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94

Epidemic listeriosis--evidence for transmission by food. N Engl J Med (1983) 11.72

Physiological differentiation of viridans streptococci. J Clin Microbiol (1977) 11.17

Presumptive identification of group A, B, and D streptococci. Appl Microbiol (1974) 8.23

Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med (1980) 7.85

Listeriosis. JAMA (1989) 7.06

Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun (1973) 7.01

Emergence of drug-resistant pneumococcal infections in the United States. JAMA (1994) 6.29

Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci. Appl Microbiol (1973) 6.17

Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15

Presumptive identification of group D streptococci: the bile-esculin test. Appl Microbiol (1970) 6.00

Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71

Epidemiology of human listeriosis. Clin Microbiol Rev (1991) 5.21

The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med (1995) 5.18

Public health policy for preventing violence. Health Aff (Millwood) (1993) 5.17

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63

Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. J Infect Dis (1991) 4.00

Nonhemolytic group B streptococci of human, bovine, and ichthyic origin. Infect Immun (1973) 3.81

Changing epidemiology of group A streptococcal infection in the USA. Lancet (1990) 3.35

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31

The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis (1996) 3.26

Phylogenetic analysis of some Aerococcus-like organisms from clinical sources: description of Helcococcus kunzii gen. nov., sp. nov. Int J Syst Bacteriol (1993) 3.16

Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species. J Clin Microbiol (1984) 3.16

Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med (1982) 3.12

Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet (1982) 3.10

Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09

Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet (1989) 3.09

Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother (1974) 3.06

Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05

The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis (1992) 3.04

The carrier state: Neisseria meningitidis. J Antimicrob Chemother (1986) 3.00

Evaluation of commercial latex agglutination reagents for grouping streptococci. J Clin Microbiol (1979) 2.95

Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90

Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA (1985) 2.87

Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis (1996) 2.85

Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85

Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group. JAMA (1992) 2.82

Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis (1990) 2.80

Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA (1990) 2.79

Presumptive identification of group A, B, and D streptococci on agar plate media. J Clin Microbiol (1979) 2.72

Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet (1991) 2.63

Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera. J Clin Microbiol (1981) 2.56

Presumptive identification of streptococci with a new test system. J Clin Microbiol (1982) 2.55

Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? J Clin Microbiol (1989) 2.51

Investigation of an outbreak of listeriosis: new hypotheses for the etiology of epidemic Listeria monocytogenes infections. J Infect Dis (1989) 2.42

Association of sporadic listeriosis with consumption of uncooked hot dogs and undercooked chicken. Lancet (1988) 2.42

Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet (1985) 2.39

Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32

Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorescence assay. J Infect Dis (1983) 2.28

Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26

Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol (1992) 2.23

Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21

Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17

Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins. JAMA (1985) 2.16

Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA (1992) 2.15

Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med (1982) 2.14

Granulicatella and Abiotrophia species from human clinical specimens. J Clin Microbiol (2001) 2.14

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J Infect Dis (1998) 2.11

Global epidemiology of meningococcal disease. Clin Microbiol Rev (1989) 2.11

Specificity study of kits for detection of group A streptococci directly from throat swabs. J Clin Microbiol (1987) 2.10

Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet (1988) 2.06

Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA (1988) 2.06

Epidemiologic aspects of legionellosis. Epidemiol Rev (1979) 2.03

Rapid identification of enterococci. J Clin Microbiol (1983) 2.03

Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother (1990) 1.93

Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis (1995) 1.93

Phenotypic and genotypic characterization of atypical Lactococcus garvieae strains isolated from water buffalos with subclinical mastitis and confirmation of L. garvieae as a senior subjective synonym of Enterococcus seriolicida. Int J Syst Bacteriol (1996) 1.92

Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA (1985) 1.91

Differentiation of Lactococcus lactis and Lactococcus garvieae from humans by comparison of whole-cell protein patterns. J Clin Microbiol (1991) 1.91

The gram positive cocci. Hum Pathol (1976) 1.90

emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. Microbiology (2000) 1.89

Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogen. Ann Intern Med (1989) 1.89

Neonatal enterococcal sepsis: case-control study and description of an outbreak. Pediatr Infect Dis J (1987) 1.89

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis (1997) 1.86

The epidemiology of listeriosis in the United States--1986. Listeriosis Study Group. Am J Epidemiol (1991) 1.84

A review of the microbiological techniques for the isolation and identification of streptococci. CRC Crit Rev Clin Lab Sci (1976) 1.84

Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol (1984) 1.81

Correlation between phenotypic characteristics and DNA relatedness within Enterococcus faecium strains. J Clin Microbiol (1995) 1.79

Comparison of three commercial rapid identification systems for the unusual gram-positive cocci Dolosigranulum pigrum, Ignavigranum ruoffiae, and Facklamia species. J Clin Microbiol (2000) 1.78

Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis (1990) 1.77

Risk factors for primary invasive Haemophilus influenzae disease: increased risk from day care attendance and school-aged household members. J Pediatr (1985) 1.76

Vancomycin-resistant Pediococcus acidilactici: nine cases of bacteremia. J Infect Dis (1990) 1.75

Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med (1983) 1.75

Antimicrobial susceptibility patterns of Streptococcus pneumoniae. Antimicrob Agents Chemother (1978) 1.75

An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med (1994) 1.73

Atmospheric growth requirements for Alloiococcus species and related gram-positive cocci. J Clin Microbiol (1996) 1.72

Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. J Clin Microbiol (1984) 1.70

Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (2001) 1.69

Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis (2000) 1.69

Enterococcus raffinosus sp. nov., Enterococcus solitarius sp. nov. and Enterococcus pseudoavium sp. nov. FEMS Microbiol Lett (1989) 1.67

Rapid diagnosis of Legionnaires' disease by direct immunofluorescent staining. Ann Intern Med (1979) 1.65

Outbreak of neonatal listeriosis associated with mineral oil. Pediatr Infect Dis J (1991) 1.64

Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA (1993) 1.63